Potential utility of the new sysmex XE 5000 red blood cell extended parameters in the study of disorders of iron metabolism

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 11, 2009, Pages 1411-1416

  Urrechaga, Eloísa ^a   Borque, Luís ^b   Escanero, Jesús F ^b  

^a HOSPITAL DE GALDAKAO   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Hypochromia; Mature erythrocyte; Microcytosis; Restricted erythropoiesis

Indexed keywords

ERYTHROPOIETIN; FERROUS GLUCONATE; HEMOGLOBIN;

ANALYZER; ANEMIA; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ERYTHROCYTE; FEMALE; HUMAN; HUMAN CELL; IRON DEFICIENCY ANEMIA; KOLMOGOROV SMIRNOV TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; RETICULOCYTE HEMOGLOBIN CONTENT; SENSITIVITY AND SPECIFICITY; STUDENT T TEST; THALASSEMIA;

ANEMIA, IRON-DEFICIENCY; ERYTHROCYTE COUNT; ERYTHROCYTES; FLOW CYTOMETRY; HEMOGLOBINS; HUMANS; IRON METABOLISM DISORDERS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 73349110102     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.301     Document Type: Article

References (28)

1. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood 2003;101:3359-3364
2. Morris MW, Williams WJ, Nelson DA. Automated blood cell counting. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, editors. Williams' hematology, 5th ed. New York: McGraw-Hill, 1995;L3.
3. Harris N, Kunicka J, Kratz A. The ADVIA 2120 hematology system: flow cytometry-based analysis of blood and body fluids in the routine hematology laboratory. Lab Hematol 2005;11:47-61.
4. Navarro JF, Macia ML. Hypochromic red cells as an indicator of iron deficiency. J Rheumatol 1997;24:804-805
5. Macdougall IC. Merits of hypochromic red cells as a marker of functional iron deficiency. Nephrol Dial Transplant 1998;13:847-849
6. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002;48:1066-1076
7. Bovy C, Gothot A, Krzesinski JM, Beguin Y. Mature erythrocyte indices: new markers of iron availability. Haematologica 2005;90:549-551
8. Bovy C, Gothot A, Delanaye P, Warling X, Krzesinski JM, Beguin Y. Mature erythrocyte parameters as new markers of functional iron deficiency in hemodialysis. Nephrol Dial Transplant 2007;22:1156-1162
9. D'Onofrio G, Zini G, Ricerca BM, Mancini S, Mango G. Automated measurement of red blood cell microcytosis and hypochromia in iron deficiency and beta-thalassemia trait. Arch Pathol Lab Med 1992;116:84-89
10. Robertson EP, Pollock A, Yauss KS, Chan LC. Use of Technicon H*1 technology in routine thalassemia screening. Med Lab Sci 1992;49:259-264
11. Jimenez CV, Minchinela J, Ros J. New indices from the H*2 analyser improve differentiation between heterozygous b or d b thalassemia and iron-deficiency anemia. Clin Lab Haem 1995;17:151-155
12. Urrechaga E. Discriminant value of % Microcytic/% Hypochromic ratio in the differential diagnosis of microcytic anemia. Clin Chem Lab Med 2008;46:1752-1758
13. Tanaka Ch, Nagai T, Nakamura M, Yamauchi Y, Noguchi K, Takimoto Y, et al. Automated hematology analyser XE 5000. Overview and basic preformance. Sysmex J Int 2007;17(Supp 3):1-6.
14. Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc 2003;78:1274-1280
15. Brugnara C, Schiller B, Moran J. Ret He and assessment of iron deficient states. Clin Lab Haem 2005;28:303-308
16. NKF-K/DOQI. NKF-K/DOQI clinical practice guideline and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006;47(Suppl 3):S11-S145.
17. Thein SL, Wallace RS. The use of synthetic oligonucleotides as specific hybridation probes in the diagnosis of genetic disorders. In: Davis KE, editor. Human genetic diseases, a practical approach. Oxford-Washington DC: IRL press, 1986:33-50.
18. Kazazian H, Boehm C. Molecular basis and prenatal diagnosis of beta-thalassemia. Blood 1988;72:1170-1176
19. Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant 2001;16:1416-1423
20. Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem 2003;49:1573-1578
21. Tassiopoulos T, Konstantopoulos K, Tassiopoulos S, Rombos Y, Alevizou-Terzaki V, Kyriaki P. Erythropoietin levels and microcytosis in heterozygous b thalassemia. Acta Haematol 1997;98:147-149
22. Lafferty JD, Crowther MA, Ali MA, Levine M. The evaluation of various mathematical RBC indices and their efficacy in discriminating between thalassemic and nonthalassemic microcytosis. Am J Clin Pathol 1996;106: 201-205
23. Beyan C, Kaptan K, Ifran A. Predictive value of discrimination indices in differential diagnosis of iron deficiency anemia and b thalassemia trait. Eur J Hematol 2007;78: 524-526
24. Briggs C, Rogers R, Thompson B, Machin SJ. New red cell parameters on the Sysmex XE-2100 as potential markers of functional iron deficiency. Infus Ther Transfus Med 2001;28:256-262
25. Buttarello M, Temporin V, Ceravolo R, Farina G, Burian P. The new reticulocyte parameter RET Y of the Sysmex XE 2100. Its use in the diagnosis and monitoring of post treatment sideropenic anemia. Am J Clin Pathol 2004; 121:489-495
26. Canals C, Remacha AF, Sarda MP, Piazuelo JM, Royo MT, Romero MA. Clinical utility of the new Sysmex XE 2100 parameter - reticulocyte hemoglobin equivalent in the diagnosis of anemia. Haematologica 2005;90:1133-1134
27. Thomas L, Franck S, Messinger M, Linssen J, Thome M, Thomas C. Reticulocyte hemoglobin measurement - comparison of two methods in the diagnosis of ironrestricted erythropoiesis. Clin Chem Lab Med 2005;43: 1193-1202
28. Mast AE, Blinder MA, Dietzen DJ. Reticulocyte haemoglobin content. Am J Hematol 2008;83:307-310